Drug Profile
Methazolamide extended release - Effcon laboratories
Latest Information Update: 28 Jun 2021
Price :
$50
*
At a glance
- Originator Effcon Laboratories
- Class Antiglaucomas; Antihyperglycaemics; Antineoplastics; Small molecules; Thiadiazoles
- Mechanism of Action Carbonic anhydrase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Unspecified